CKD-bioMatch Trial Aims to Optimize Chronic Kidney Disease Treatment via Biomarker-Guided Therapy
A Biomarker-targeted Clinical Trial to Optimize Treatment for Patients With Chronic Kidney Disease
Abstract
The CKD-bioMatch study will evaluate a biomarker-targeted treatment approach against standard of care to reduce eGFR decline in CKD patients with albuminuria.